No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Frederieke H van der Baan, Andrew Berchuck, Sharon E Johnatty, Katja K Aben, Bjarni A Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L Andrulis, Hoda Anton-Culver, Nick Orr

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint Dive into the research topics of 'No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences